These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21251964)

  • 1. The application of monolayer studies in the understanding of liposomal formulations.
    Moghaddam B; Ali MH; Wilkhu J; Kirby DJ; Mohammed AR; Zheng Q; Perrie Y
    Int J Pharm; 2011 Sep; 417(1-2):235-44. PubMed ID: 21251964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of curcumin with lipid monolayers and liposomal bilayers.
    Karewicz A; Bielska D; Gzyl-Malcher B; Kepczynski M; Lach R; Nowakowska M
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):231-9. PubMed ID: 21778041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs.
    Ali MH; Moghaddam B; Kirby DJ; Mohammed AR; Perrie Y
    Int J Pharm; 2013 Aug; 453(1):225-32. PubMed ID: 22766442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined macro- and microrheometer for use with Langmuir monolayers.
    Walder R; Schmidt CF; Dennin M
    Rev Sci Instrum; 2008 Jun; 79(6):063905. PubMed ID: 18601415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes.
    Zhao L; Feng SS
    J Colloid Interface Sci; 2004 Jun; 274(1):55-68. PubMed ID: 15120278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which physical and structural factors of liposome carriers control their drug-loading efficiency?
    Kepczyński M; Nawalany K; Kumorek M; Kobierska A; Jachimska B; Nowakowska M
    Chem Phys Lipids; 2008 Sep; 155(1):7-15. PubMed ID: 18590712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
    Schroeder A; Kost J; Barenholz Y
    Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
    Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
    Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical studies on collagen-lipid interaction.
    Mady MM
    J Biosci Bioeng; 2007 Aug; 104(2):144-8. PubMed ID: 17884660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the in situ structural and interfacial properties of the cationic hydrophobic heteropolypeptide, KL4, in lung surfactant bilayer and monolayer models at the air-water interface: implications for pulmonary surfactant delivery.
    Mansour HM; Damodaran S; Zografi G
    Mol Pharm; 2008; 5(5):681-95. PubMed ID: 18630875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between equilibrium spreading pressure and phase equilibria of phospholipid bilayers and monolayers at the air-water interface.
    Mansour HM; Zografi G
    Langmuir; 2007 Mar; 23(7):3809-19. PubMed ID: 17323986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane.
    Zhao L; Feng SS; Kocherginsky N; Kostetski I
    Int J Pharm; 2007 Jun; 338(1-2):258-66. PubMed ID: 17337138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.
    Song G; Wu H; Yoshino K; Zamboni WC
    J Liposome Res; 2012 Sep; 22(3):177-92. PubMed ID: 22332871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using microcantilevers to study the interactions of lipid bilayers with solid surfaces.
    Liu KW; Biswal SL
    Anal Chem; 2010 Sep; 82(18):7527-32. PubMed ID: 20726504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ; Cullis PR
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposil, a promising composite material for drug storage and release.
    Bégu S; Aubert Pouëssel A; Lerner DA; Tourné-Péteilh C; Devoisselle JM
    J Control Release; 2007 Mar; 118(1):1-6. PubMed ID: 17250924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of the thienopyridine derivatives loaded liposomes and study on the effect of compound-lipid interaction on release behavior.
    Liu J; Tang J; He H; Cai LL; Huang Y; Wei X; Luo M; Wang B; Gao X; Yang C; Hu T; Song X; Yi T; Yang L; Xie Y; Tong A; Gou L; Zhao Y; Zheng Y
    Drug Deliv; 2012; 19(5):247-54. PubMed ID: 22823892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.